Author threatens to sue Elsevier if paper remains retracted

Computational Materials Science

An author is prepared to sue Elsevier if it doesn’t un-retract his paper.

Computational Materials Science published two papers by the same author just eight months apart; nearly four years later, the journal pulled one for duplication. Author Masoud Panjepour, affiliated with Isfahan University of Technology in Iran, told us that he is working with a lawyer to negotiate a solution. However, if the publisher does not un-retract the paper, he does “not rule out filing a lawsuit.”

Here’s the retraction notice for “The effect of temperature on the grain growth of nanocrystalline metals and its simulation by molecular dynamics method,” which appeared last November:

Continue reading Author threatens to sue Elsevier if paper remains retracted

Paper plagiarizes from handwritten manuscript

semiform groupThis case of plagiarism is a little weirder than usual.

A paper has been retracted from Semigroup Forum because it includes material taken from another researcher’s manuscript — which was handwritten. In fact, the same journal had already published a paper by the plagiarized researcher, also based on the same manuscript. The journal editor told us that, although the two papers are similar, they are not word-for-word copies, and thus escaped detection.

The retraction notice for “Varieties of bands with a semilattice transversal” gives more details about the handwritten manuscript:

Continue reading Paper plagiarizes from handwritten manuscript

“Lack of scientific contributions and novelty” fells math paper

pms

A journal apparently changed its mind about the uniqueness of a math paper, published last year.

We’ll get right to the brief retraction noticeContinue reading “Lack of scientific contributions and novelty” fells math paper

Editors say they missed “fairly obvious clues” of third party tampering, publish fake peer reviews

BJCP Cover

The editors of a journal that recently retracted a paper after the peer-review process was “compromised” have published the fake reviews, along with additional details about the case.

In the editorial titled “Organised crime against the academic peer review system,” Adam Cohen and other editors at the British Journal of Clinical Pharmacology say they missed “several fairly obvious clues that should have set alarm bells ringing.” For instance, the glowing reviews from supposed high-profile researchers at Ivy League institutions were returned within a few days, were riddled with grammar problems, and the authors had no previous publications. 

The case is one of many we’ve recently seen in which papers are pulled due to actions of a third party

The paper was submitted on August 5, 2015. From the beginning, the timing was suspect, Cohen — the director for the Centre for Human Drug Research in The Netherlands — and his colleagues note: Continue reading Editors say they missed “fairly obvious clues” of third party tampering, publish fake peer reviews

Authors retract non-reproducible Cell paper

CellAuthors have retracted a paper from Cell after they were unable to reproduce data in two figures, compromising their confidence in some of the findings.

The authors revisited their experiments after another lab was unable to replicate their data, about proteins that may play a role in lung cancer.

The first author told Nature News in 2013 that the paper may have helped her secure her current position at the Novartis Institutes for Biomedical Research in Massachusetts.

Pulling “Cytohesins are cytoplasmic ErbB receptor activators” appears to be a case of doing the right thing, given the detailed retraction notice:

Continue reading Authors retract non-reproducible Cell paper

Software glitch — not intentional manipulation — sunk immunology paper, says author

kuo photo
A black box appears over the control lane on the left

New evidence suggests a retracted paper was felled not by intentional manipulation — as it first appeared — but by a software glitch.

In 2014, we reported that Biochemical Journal had retracted a paper on suspicion it contained “shoddy Photoshopping”  — someone appeared to have blacked out a control lane in one figure. Now there’s evidence that it wasn’t done on purpose: An investigation at Duke into eight papers, including the Biochemical Journal paper, did not find evidence of misconduct; lead author Paul Kuo, currently chair of surgery at Loyola Medicine, told us that a glitch in the software caused the black box. Nevertheless, the journal does not plan to un-retract the paper. Continue reading Software glitch — not intentional manipulation — sunk immunology paper, says author

Journal pulls parasite paper over potential for patient harm

Parasitology ResearchA journal has retracted a paper about a molecular diagnosis for leishmaniasis out of concern it could lead to incorrect clinical diagnoses. 

According to Parasitology Research, all data behind the figures in the main manuscript and supporting information are correct, but the authors’ misinterpretation of the data could lead doctors to diagnose patients incorrectly. 

Let’s take a look at the retraction notice, which tells us a bit more about the nature of the problem: Continue reading Journal pulls parasite paper over potential for patient harm

Nature fixes highly cited paper suggesting food additives hurt the gut

Nature_latest coverA 2015 study about dietary emulsifiers has been corrected by Nature after another researcher pointed out a few ambiguities.

When it first appeared, the study — which showed emulsifiers cause inflammation in the guts of mice — received a fair amount of media attention, including from Nature’s own news department. But since publication, a researcher noted some imprecision around the ages of mice used in the sample, affecting the paper’s calculations of weight gain over time. Andrew Gewirtz, co-author of the study from Georgia State University, told us the change did not affect the conclusions of the paper.

Here’s the corrigendum for “Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome”: Continue reading Nature fixes highly cited paper suggesting food additives hurt the gut

What happened after a journal decided to get tough on plagiarism?

Reiss
Carol Shoshkes Reiss

In July 2015, DNA and Cell Biology began routinely scanning manuscript submissions for plagiarism using iThenticate; since then, it’s rejected between four and six manuscripts each month for that reason alone. Additional submissions have been rejected after the journal realized the authors had digitally altered figures. The level of misconduct “shocked” editor-in-chief Carol Shoshkes Reiss, as she wrote in a recent editorial for the journal. She spoke to us about the strict measures the journal has adopted in response to these incidents.

Retraction Watch: Why did you decide to begin scanning submissions for plagiarized text using iThenticate™ software in July, 2015? Did something prompt that decision? Continue reading What happened after a journal decided to get tough on plagiarism?

Doing the right thing: Authors share data, retract when colleague finds error

no spine minimum. full size. Editor: Holly JEM: Leslie RTP: Karen Geist ancac3

A pair of chemical engineers has retracted a paper after another researcher was unable to replicate their work, in a case that we consider an example of doing the right thing.

Dennis Prieve, at Carnegie Mellon University, was interested in applying the paper — on how systems of molecules known as “reverse micelles” conduct electrical charge — to his own work, but was having trouble repeating the calculations. So Prieve contacted the authors — John Berg and his PhD student Edward Michor, based at the University of Washington — who supplied him with their original data.

It took several weeks of back and forth to figure out the problem, Michor told us, as the paper was published in 2012, so he had to decipher his old notes. When they found that several incorrect values were used in the paper, the authors issued a retraction notice, published in March:

Continue reading Doing the right thing: Authors share data, retract when colleague finds error